[Combined antidote therapy in experimental animals poisoned with Tabun, Sarin and Soman].
D000818:Animals; D000931:Antidotes / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000037:antagonists & inhibitors*; D003517:Cyclopentanes / Q000627:therapeutic use; D008297:Male; D063065:Organophosphonates / Q000633:toxicity*; D010756:Phosphoric Acids / Q000633:toxicity*; D011220:Pralidoxime Compounds / Q000627:therapeutic use*; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D051381:Rats; D014273:Triflupromazine / Q000627:therapeutic use*
D000931:Antidotes; D002800:Cholinesterase Inhibitors; D003517:Cyclopentanes; D063065:Organophosphonates; D010756:Phosphoric Acids; D011220:Pralidoxime Compounds; D011726:Pyridinium Compounds; D014273:Triflupromazine
Zur kombinierten Antidottherapie der tierexperimentellen Vergiftung mit Tabun, Sarin und Soman.